Self-Adjuvanting Adenoviral Nanovaccine for Effective T-Cell-Mediated Immunity and Long-Lasting Memory Cell Activation against Tuberculosis

ACS Publications·Oct 28

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Researchers are exploring the development of nanovaccines for various applications, including infectious diseases and cancer. These nanovaccines are being designed to induce effective immune responses, with some studies focusing on their potential to provide long-lasting immunity. The specific uses and effectiveness of these nanovaccines are being investigated in different areas, including tuberculosis and cancer immunotherapy.

Full coverage

Biomimetic nanovaccine-mediated multivalent IL-15 self-transpresentation (MIST) for potent and safe cancer immunotherapy

Nature·Oct 24

mRNA vaccines and their delivery strategies: A journey from infectious diseases to cancer

ScienceDirect.com·Jan 3

Recent advances of nanovaccines on cancer theranostics

Frontiers·Feb 11

Nanovaccines for Advancing Long-Lasting Immunity against Infectious Diseases

ACS Publications·Dec 6

Self-adjuvanting nanovaccines boost lung-resident CD4+ T cell immune responses in BCG-primed mice | npj Vaccines

Nature·Apr 26

Dendritic cell-based nanovaccines for cancer immunotherapy

ScienceDirect.com·Sep 17

The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects

Frontiers·Feb 7

Therapeutic cancer vaccines: advancements, challenges and prospects | Signal Transduction and Targeted Therapy

Nature·Dec 13

View original report at ACS Publications ↗

Fetching the latest headlines…